Buyer Database · Sales Agent · Updated
Fox Entertainment Global
Fox Entertainment Global is a fledgling international sales and distribution outfit actively licensing its comedy and animation slate into AVoD-driven markets, with Best Medicine as its current flagship title in active territory rollout.
Current mandate
Fox Entertainment Global (FEG) is currently positioned as an international rights seller focused on advertising-supported distribution, with a stated priority on monetising original content through distribution rather than expanding SVoD footprints. The company is actively pursuing additional international licensing deals for Best Medicine beyond already-announced territories, making that title the clearest entry point for prospective buyers and co-production partners. FEG's executives have publicly signalled that AVoD is the strategic lens through which they evaluate new deals, citing the market as one "just taking off" and likely to inject significant capital into the content ecosystem. Comedy and animation series sit at the centre of the current slate; Animal Control, a primetime comedy, is reportedly testing well in trial. The company launched in October and describes its opening months as having gone better than expected, according to its CEO.
Recent representation activity includes the appointment of Valerie Meraz as SVP, Content and Acquisitions (October 2025), signalling an active build-out of the acquisitions pipeline alongside outbound sales. FEG's dual mandate of selling existing content and cultivating co-production relationships distinguishes it from pure-play distributors and suggests openness to structured partnerships, not only straight licensing transactions.
Sellers and producers seeking representation or licensing should approach FEG through its Content and Acquisitions division, now led by Meraz. Given the company's explicit focus on AVoD monetisation and its stated interest in building co-production relationships, projects that carry advertising-friendly formats, comedy or animation genres, and international co-production potential are best positioned for consideration.
Signature peaks
- 24 Active Records (12mo) — Total tracked deal and activity records over the past 12 months
- 1 Deal Velocity (30d) — Signal activity recorded in the most recent 30-day window
- Jun 2026 Latest Signal — Most recent tracked activity, per platform data
Mandate dimensions
- Genre focus
- Not disclosed
- Territory focus
- Not disclosed
- Budget tier (observed)
- Not disclosed
- Access pattern
- Primary contact is the Content and Acquisitions division, led by SVP Valerie Meraz (appointed October 2025). FEG's dual mandate of outbound licensing and inbound co-production development means both finished content and earlier-stage projects with advertising-friendly formats may be considered. Comedy and animation genres, AVoD-compatible rights structures, and co-production frameworks are the strongest alignment signals to lead with in any outreach.
- Deal structure
- FEG operates as an international rights seller and licensor, with a stated preference for advertising-supported distribution windows over SVoD expansion. Deal structures in active discussion include territory-by-territory licensing (as evidenced by the ongoing Best Medicine rollout) and co-production arrangements designed to generate new content alongside distribution. Budget terms are not disclosed in available records. The company does not position itself as a pure-play distributor; relationship-based co-production is an explicit part of its commercial model.
Recent representations
-
Valerie Meraz appointed SVP, Content & Acquisitions
-
Valerie Meraz (SVP Content & Acquisitions)
Market context
We don't just sell content but also attract relationships to collectively generate new content.
Fox Entertainment Global (FEG) is currently positioned as an international rights seller focused on advertising-supported distribution, with a stated priority on monetising original content through distribution rather than expanding SVoD footprints. The company is actively pursuing additional international licensing deals for Best Medicine beyond already-announced territories, making that title the clearest entry point for prospective buyers and co-production partners. FEG's executives have publicly signalled that AVoD is the strategic lens through which they evaluate new deals, citing the market as one "just taking off" and likely to inject significant capital into the content ecosystem. Comedy and animation series sit at the centre of the current slate; Animal Control, a primetime comedy, is reportedly testing well in trial. The company launched in October and describes its opening months as having gone better than expected, according to its CEO.
Common questions about Fox Entertainment Global
What films and series does Fox Entertainment Global represent for international rights?
FEG's most publicly active title in international licensing is Best Medicine, for which the company is actively pursuing deals beyond already-announced territories. The company also has primetime comedy Animal Control on its slate, which is reportedly testing well in trial. FEG's stated genre focus centres on comedy and animation series, consistent with Fox Entertainment's broader programming identity. Producers with titles in those categories are the most natural fit for representation conversations.
Does Fox Entertainment Global engage in pre-sales, and how does that process work?
FEG has signalled openness to co-production relationships as part of its distribution strategy, with executives explicitly stating the company seeks to attract partnerships that collectively generate new content, not only sell finished product. This suggests pre-sale and co-production structures are within scope. The company's AVoD-first positioning means pre-sale conversations are likely framed around advertising-supported window strategies rather than traditional SVoD or pay-TV output deals.
Which markets is Fox Entertainment Global most active in for international licensing?
FEG has not publicly itemised every territory in its current licensing activity, but the company is described as pursuing additional international licensing deals for Best Medicine beyond already-announced territories, implying a multi-territory rollout is underway. Executives have specifically highlighted the AVoD market as a strategic priority, suggesting territories with developed or fast-growing ad-supported streaming ecosystems are the primary focus. No specific named territories have been confirmed in available coverage.
How do you reach Fox Entertainment Global to pitch a project or discuss representation?
The clearest access point is the Content and Acquisitions division, now headed by Valerie Meraz, who was appointed SVP, Content and Acquisitions in October 2025. FEG tracks 36 decision makers across its operation according to platform data, indicating a reasonably sized team. Given the company's stated interest in co-production relationships alongside straight licensing, pitches that frame a project within an advertising-supported distribution model are likely to receive the most traction.
What are Fox Entertainment Global's strongest or most prioritised territories?
Available coverage does not confirm specific named priority territories. FEG's strategic commentary points to markets where AVoD is growing rapidly as the primary opportunity set, with executives describing the AVoD market as one that is 'just taking off' and expected to bring in significant capital. Territories with established or emerging ad-supported streaming infrastructure are therefore the implied focus. Sellers with rights available in those markets should reference FEG's AVoD mandate directly when making contact.
Is Fox Entertainment Global actively acquiring and representing new content right now?
Yes. FEG launched in October and its CEO has stated the opening months went better than expected. The October 2025 appointment of Valerie Meraz as SVP, Content and Acquisitions signals an active build-out of the inbound pipeline. The company recorded 24 activity records over the past 12 months per platform tracking, and its seeking statement confirms ongoing pursuit of international licensing deals for Best Medicine, with additional representation activity implied by the new acquisitions leadership hire.
Adjacent buyers in this lane
- Banijay Rights — Banijay Rights is actively placing premium scripted series and factual formats across international
- mk2 Films — mk2 Films is riding a high-profile awards season while positioning Justine Triet's psychological thr
- Keshet International — Keshet International is actively taking its supernatural drama Nutuk to Mipcom buyers while a local
- HanWay Films — HanWay Films actively represents international rights to prestige, female-driven dramas and high-con
Related reading
Match your script to Fox Entertainment Global
This is a public snapshot of Fox Entertainment Global, kept current from trade-press signals. Inside ScriptMatch, upload your script to see whether Fox Entertainment Global fits, why, and exactly how to reach them. Start a free 7-day trial or try the free buyer-match tool.